Read More Pharma Industry News Reneo Pharmaceuticals gets FDA ODD for REN001 in primary mitochondrial myopathies Reneo Pharmaceuticals has been granted the orphan drug designation (ODD) for its lead drug candidate REN001 from the… bypharmanewsdailyJune 23, 2020